Elo Mutual Pension Insurance Co Takes $1.53 Million Position in Encompass Health Corporation $EHC

Elo Mutual Pension Insurance Co acquired a new position in shares of Encompass Health Corporation (NYSE:EHC) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 12,057 shares of the company’s stock, valued at approximately $1,531,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in EHC. Citizens National Bank Trust Department acquired a new stake in shares of Encompass Health during the third quarter worth about $26,000. First Horizon Corp bought a new stake in Encompass Health during the 3rd quarter worth approximately $34,000. Westside Investment Management Inc. raised its holdings in Encompass Health by 56.7% during the 3rd quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after buying an additional 101 shares during the period. Assetmark Inc. boosted its holdings in shares of Encompass Health by 88.1% in the third quarter. Assetmark Inc. now owns 299 shares of the company’s stock valued at $38,000 after buying an additional 140 shares during the period. Finally, Root Financial Partners LLC acquired a new position in shares of Encompass Health in the third quarter valued at approximately $39,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on EHC shares. Barclays raised their price objective on shares of Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a report on Friday, February 6th. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Finally, Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $143.29.

Encompass Health Stock Down 1.1%

Encompass Health stock opened at $107.79 on Friday. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 1-year low of $92.53 and a 1-year high of $127.99. The company has a fifty day simple moving average of $103.94 and a 200 day simple moving average of $113.81. The company has a market cap of $10.72 billion, a P/E ratio of 19.46, a price-to-earnings-growth ratio of 2.09 and a beta of 0.71.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, February 5th. The company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. The company had revenue of $3.09 billion during the quarter, compared to the consensus estimate of $1.54 billion. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The company’s quarterly revenue was up 9.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.17 EPS. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Research analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be given a dividend of $0.19 per share. The ex-dividend date of this dividend is Wednesday, April 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s payout ratio is 13.72%.

Insider Activity

In other news, CEO Mark J. Tarr sold 150,000 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total value of $16,746,000.00. Following the completion of the sale, the chief executive officer owned 377,070 shares of the company’s stock, valued at approximately $42,096,094.80. This represents a 28.46% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 2.00% of the stock is currently owned by corporate insiders.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.